Michael C. Dugan's Insider Trades & SAST Disclosures

Michael C. Dugan's most recent trade in Biocept Inc was a trade of 150,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 31, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Biocept Inc
Michael C. Dugan Chief Med Off & Med. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2021 150,000 150,000 - - Employee Stock Option (right to buy)
Biocept Inc
Michael C. Dugan Chief Med Off & Med. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2020 69,000 69,000 - - Employee Stock Option (right to buy)
Biocept Inc
Michael C. Dugan Chief Med Off & Med. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2020 54,900 54,900 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades